心理药物坚持状态及其决定因素在严重情绪和精神障碍的老年人中:一个多中心的横截面研究
Woretaw Sisay Zewdu1, Tigabu Eskeziya Zerihun2, Desalegn Addis Mussie2
1Department of Pharmacology and Toxicology, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Therapeutic advances in psychopharmacology
|November 7, 2025
概括
在埃塞俄比亚,患有严重精神障碍的老年人中,低于最佳的精神药物药物坚持是常见的. 关键预测因素包括低识字率,负面的治疗态度和高药物复杂性.
科学领域:
- 老年精神病学是一门精神病学专业.
- 心理健康研究 心理健康研究
- 公共卫生 公共卫生
背景情况:
- 不坚持精神病治疗会对整个护理连续性的结果产生负面影响.
- 有限的数据存在于资源有限的环境中药物坚持,特别是对于严重精神障碍的老年人.
- 了解坚持挑战对于改善老年精神卫生保健至关重要.
研究的目的:
- 为了调查严重精神障碍的老年人心理药物坚持行为.
- 为了确定这种脆弱人群中药物坚持的预测因素.
- 为改善治疗结果提供有针对性的干预措施的信息.
主要方法:
- 一项基于医院的横截面研究在埃塞俄比亚南贡达尔地区进行.
- 一种多阶段采样技术招募了423名患有严重精神障碍的老年人.
- 采用问卷和医疗记录收集数据,评估守,治疗方案复杂性,社会支持,态度和耻辱感.
主要成果:
- 超过60%的参与者表现出低于最佳的精神药物药物坚持.
- 重要的预测因素包括年龄,教育,坚持咨询,治疗态度,记忆辅助,耻辱感,洞察力,社会支持,物质使用,并发症,不良药物反应,药物治疗方案的复杂性和多药性.
- 这些因素凸显出一个复杂的相互作用,影响了这一群体的坚持.
结论:
- 在埃塞俄比亚医院中,低于最佳的精神药物药物坚持是严重精神障碍的老年人面临的重大挑战.
- 政策制定者应该制定基于证据的战略,以解决识别的预测因素,如低识字率,负面态度,高耻辱和复杂的药物治疗方案.
- 干预措施必须优先考虑具有特定风险因素的个体,以改善坚持和心理健康护理结果.
相关概念视频
01:28Drug Therapy
236
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
236
01:26Psychosis: Goals of Pharmacotherapy
453
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
453
01:28Psychosis and Antipsychotic Drugs: Overview
788
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
788
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
01:15Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213